Crossmark

Oral Administration of the Antimicrobial Peptide Mastoparan X Alleviates Enterohemorrhagic Escherichia coli–Induced Intestinal Inflammation and Regulates the Gut Microbiota

Crossref DOI link: https://doi.org/10.1007/s12602-022-10013-x

Published Online: 2022-12-14

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Xue Qin

Wang, Lei

Zhu, Chun Ling

Xue, Xiang Hong

Xia, Xiao Jing

Wu, Xi Long

Wu, Yun Di

Liu, Shan Qin

Zhang, Gai Ping

Bai, Yue Yu

Fotina, Hanna

Hu, Jian He
License Information

Text and Data Mining valid from 2022-12-14

Version of Record valid from 2022-12-14
More Information

Article History

Accepted: 18 November 2022

First Online: 14 December 2022

Declarations

:

: This article does not contain any studies involving human participants performed by any of the authors. This study was approved by the Animal Welfare and Research Ethics Committee and was approved by the Animal Ethics Committee at Henan Institute of Science and Technology (01 June 2021).

: All authors consent to the publication of this article.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below